Michigan Woman Files Option® IVC Filter Lawsuit
A woman from Michigan has filed a lawsuit after her "retrievable" blood clot filter became tilted and embedded in her vein.
Jury Awards $28 Million in Xarelto Bleeding Injury Lawsuit
A jury in Philadelphia has slammed Bayer and Johnson & Johnson with a $28 million verdict in favor of plaintiffs who were injured by bleeding after taking the blood-thinning drug Xarelto.
Tennessee Woman Files IVC Filter Lawsuit
A woman from Tennessee has filed a lawsuit against the manufacturers of a "retrievable" IVC Filter that could not be removed because it became embedded in her vein 3 months after it was implanted.
Camso Recalls Dirt-to-Snow Bike Conversion Kits
Camso is recalling DTS 129 "dirt to snow" off-road motorbike conversion kits because a pin that secures the brake pads can loosen, resulting in failure of the brake system.
Australia Bans Vaginal Mesh for Safety Risks
Australian safety regulators have banned the use of transvaginal mesh implants because the risks likely outweighs any benefits.
Flu Shot Only 10% Effective Against H3N2 This Year
Doctors are predicting a severe flu season in the U.S. after studies found that this year's flu shot was only 10% effective against influenza A (H3N2) and Australia suffered record-high numbers of flu illnesses.
FDA Urges Limbrel Recall for Liver and Lung Injury Risks
The FDA has asked Primus Pharmaceuticals to voluntarily recall Limbrel, a medical food that is advertised to treat arthritis, because it is associated with life-threatening liver injury and an inflammatory lung disease called hypersensitivity pneumonitis.
Metabo Recalls Rat Tail Angle Grinders
About 1,100 Metabo Rat Tail Angle Grinders were recalled because the "on" switch can get stuck, posing a laceration hazard.
Judge Upholds $110 Million Baby Powder Cancer Verdict
A judge in Missouri has upheld a $110 million jury verdict in favor of a woman who was diagnosed with cancer after using baby powder, after finding that Johnson & Johnson had a substantial link to Missouri.